Navigation Links
EANS-News: Alapis Announces its Share Capital Increase to Raise c. EUR 451.1 million
Date:8/6/2009

ease through one or more of its wholly owned subsidiaries by investing approximately EUR 90.2 million through the exercise of 196,120,044 rights, representing 20% of the new ordinary shares. Such rights will be acquired from Dr. Lavrentis Lavrentiadis or in the open market. The Company was also informed that Dr.Lavrentiadis is a director of the general partner of Lamda Partners L.P.

A syndicate of international firms composed of ABN AMRO, BofA Merrill Lynch, BNP PARIBAS, Deutsche Bank AG London Branch and Jefferies has agreed to subscribe or procure subscribers for any new shares which may remain unsubscribed at the end of the subscription period, subject to customary terms and conditions.

The Company's prospectus that will be prepared in relation to the share capital increase will be subject to approval by the Hellenic Capital Market Commission.

The Company will endeavour to complete the capital increase by the end of September, subject to obtaining all regulatory and other approvals in a Timely manner.

The decision of the Board of Directors is pursuant to the authority given to it by the second repeat Extraordinary General Meeting of Alapis' shareholders held on 29 September 2008.

    Further inquiry note:

    Norbert Schmidt-Gollas
    n.gollas@alapis.eu
   http://www.alapis.eu
    Alapis
    Aftokratoros Nikolaou str., No 2,
    p.c.176 71 Athens
    tel. +30-213-0175000-1
    fax +30-210-9238460

    emitter:         ALAPIS S.A.
                     Aftokratoros Nikalaou str. 2
                     17671 Athen
    phone:           +30-213-0175000-1
    FAX:             +30-210-923-8460
    mail:            info@alapis.eu
    WWW:            http://www.alapis.eu
    sector:          Pharmaceu
'/>"/>
SOURCE ALAPIS S.A.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
(Date:4/17/2014)... uncommon these days to find a colored ribbon representing a ... cancer. But what color ribbon does one think of with ... color, for many suffering from the disease, black may be ... study consisting of lung cancer patients, primarily smokers between the ... light on the stigma often felt by these patients, the ...
(Date:4/17/2014)... A new study has found that India,s shocking rates ... debt-ridden farmers who are clinging to tiny smallholdings ... ,cash crops, such as cotton and coffee, that are ... supports a range of previous case studies that point ... sector following the ,liberalisation, of the nation,s economy during ...
(Date:4/17/2014)... the leading weapon against the deadly disease could be ... indicating it simply needs to be administered differently. , ... anti-malarial drug chloroquine in treating and preventing the mosquito-bourne ... a million people each year around the world. , ... chloroquine, but research carried out at the Australian National ...
(Date:4/16/2014)... Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that final ... solid tumors, including long-term patient follow-up, have been published ... 232). The data demonstrate robust antibody and T cell ... very advanced cancers and suggest that CDX-1401 may predispose ...
Breaking Medicine News(10 mins):Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3Health News:Scientists find new way to fight malaria drug resistance 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4
... ... in Italy, in conjunction with a team of doctors from the ... confirming that Pecorino Romano Cheese contains high amounts of CLA (Conjugated ... food groups. The study reveals that even in small amounts, ...
... Yummy commercial food smells contain noxious gases, researchers say ... aromas that restaurants emit are actually a type of ... health and the environment, U.S. researchers report. , Gases ... out by commercial food cooking, according to Deborah Gross, ...
... ... for your interview. One Portland, Oregon business is providing support—literally—for today’s job seekers. ... (PRWEB) March 24, ... ), today announced a special discount offer for those seeking employment and looking for ...
... ... a healthcare consulting firm, launches new corporate website with enhanced content, navigation and performance. ... ... consulting services for the healthcare industry, is pleased to announce that it has launched ...
... ... and with celebrity appeal, generating success in a difficult economy. , ... (PRWEB) March 24, 2010 -- The ... celebrities., , ,Leeza Gibbons, popular entertainment personality and National Spokesperson for ZERONA, has proven ...
... ... asks that you join in recognizing all physicians on National Doctor,s Day, March 30 -- ... ... March 30 is National Doctor’s Day. The American Board of Physician Specialties (ABPS) ...
Cached Medicine News:Health News:Say Cheese! New Study Confirms Health Benefits of Pecorino Romano Cheese 2Health News:What's Cookin'? It Could Be Air Pollution 2Health News:Your Posture Can Make or Break Your Job Interview; PostureNOW Offers 33% Off Its Posture Corrective Brace to Job Seekers Nationwide 2Health News:Leading Healthcare Human Resource Consulting Firm, Integrated Healthcare Strategies, Launches New Website 2Health News:Leading Healthcare Human Resource Consulting Firm, Integrated Healthcare Strategies, Launches New Website 3Health News:Leeza Gibbons and ZERONA Equals a Winning Combination 2Health News:American Board of Physician Specialties (ABPS) Celebrates Doctor's Day 2010 2
(Date:1/14/2014)... , Jan. 14, 2014   NuAire , a manufacturer of ergonomically ... with Hitachi Koki of Japan ... North America . NuAire will utilize its network of ... Canada to offer assistance in application use, ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
(Date:1/14/2014)...   Evidera , a leading provider of evidence-based solutions ... Drug Evaluation and Research (CDER), U.S. Food and Drug ... for a patient-reported outcome (PRO) measure in drug development: ... [EXACT] for Measurement of Symptoms of Acute Bacterial Exacerbation ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
Curved, soft flexible tip allows atraumatic entry through a retinal tear or hole for aspiration of subretinal fluids. 20 gauge x 25 mm cannula attached to 25 gauge x 6 mm tip with 13 mm flexible tubi...
20 gauge x 8 mm with 15 cm high pressure extension tube preattached to a 10C ring control syringe. 3 per box....
Sharp tip with cutting edge bent to 50 degrees fits 19 gauge or 20 gauge instrument port, 20 gauge instrument port, 20 gauge x 25 mm tapering to 25 gauge x 4.76 mm. 10 per box....
Angled, 20 gauge x 25 mm cannula with 30 gauge x 5 mm tip. 30 gauge cannula extends into hub 2 mm from end of hub, angled 45 degrees 2.5 mm from tip. 10 per box....
Medicine Products: